Saluda Medical Receives FDA Approval for First Automated Programming Platform in SCS
EVA™ Approved for Use with the Evoke® Smart Loop System in the U.S. Potential to Improve Outcomes and Reduce Burden of Care for Chronic Pain Patients Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with chronic neurological conditions, today announced United […]